login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PULSE BIOSCIENCES INC (PLSE) Stock News
USA
- NASDAQ:PLSE -
US74587B1017
-
Common Stock
16.64
USD
+0.9 (+5.72%)
Last: 9/16/2025, 6:02:10 PM
16.64
USD
0 (0%)
After Hours:
9/16/2025, 6:02:10 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PLSE Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Pulse Biosciences, Inc.
Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting
9 days ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
13 days ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Benzinga
- Mentions:
MSC
ELUT
ACIW
JYNT
...
Earnings Scheduled For May 8, 2025
15 days ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study
20 days ago - By: Zacks Investment Research
- Mentions:
BSX
WST
MEDP
PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment
22 days ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid
a month ago - By: The Motley Fool
Pulse Biosciences Cash Jumps in Q2
a month ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
a month ago - By: Benzinga
- Mentions:
BKV
IMCC
VALN
PRTS
...
Earnings Scheduled For August 12, 2025
2 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference
2 months ago - By: Pulse Biosciences
Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025
2 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
4 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
5 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
5 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
5 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
6 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
6 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
6 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
7 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
7 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
8 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
8 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
8 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
8 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
9 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
9 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
9 months ago - By: Pulse Biosciences, Inc.
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
Please enable JavaScript to continue using this application.